Where Do Weight Loss Clinics Get Compounded GLP-1 Medications?

If you are a licensed medical provider running a weight loss program, you have probably asked this question — or had a patient ask it about you. Where does compounded semaglutide or tirzepatide actually come from? Who makes it? How do clinics get access to it? And how do you know the supply is compliant?

The short answer: clinics source compounded GLP-1 preparations through licensed 503A compounding pharmacies and 503B outsourcing facilities. The longer answer involves understanding how those channels work, what the compliance requirements are, and how to find a supply partner that can serve your clinic reliably across both.

MedClinic Partners is that supply partner for thousands of licensed providers across all 50 states.

A 503A pharmacy is a state-licensed compounding pharmacy that prepares medications in response to valid prescriptions for identified patients. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, these pharmacies can compound medications — including semaglutide and tirzepatide — that are not commercially available or that meet specific patient needs that the commercial product cannot address.

For weight loss clinics, 503A is the channel for:

• Patient-specific prescriptions at custom strengths
• Formulations with additives like glycine or B12
• Patients who need a specific dosing form or concentration not available commercially

503A pharmacies are regulated primarily at the state level, though they must also comply with applicable federal requirements. Quality standards vary by state and by pharmacy. When evaluating a 503A supplier, the key questions are: What is their state licensure status? Do they provide third-party COAs? What are their BUD (beyond-use date) standards?

A 503B outsourcing facility is a federally registered facility that produces non-patient-specific compounded preparations under cGMP (current Good Manufacturing Practice) conditions. Unlike 503A pharmacies, 503B facilities do not require a patient-specific prescription — they can sell directly to licensed healthcare practitioners for office use.

For weight loss clinics, 503B is the channel for:

• Volume supply of standard GLP-1 preparations
• cGMP-manufactured product with robust quality documentation
• Consistent batch-to-batch quality for high-volume practices

503B facilities are regulated by the FDA and subject to cGMP inspections. The quality documentation standards are higher than 503A — which is why many practices prefer 503B supply for their core GLP protocols.

A clinic running a serious GLP-1 program typically needs both 503A and 503B access. Standard protocols at volume go through 503B. Patient-specific needs — custom strengths, specific additives, unusual dosing forms — go through 503A. Managing two separate vendor relationships for these channels is operationally inefficient.

MedClinic Partners solves this by providing access to both channels through a single portal.

MedClinic Partners is a B2B facilitation platform for licensed medical providers. We are not a pharmacy. We are not a manufacturer. We are the connection between licensed providers and independently licensed 503A and 503B compounding partners — with the quality documentation standards, cold chain logistics, and compliance infrastructure that serious practices require.

What we provide:

• 503A and 503B access through one portal. No need to manage separate vendor relationships for different supply channels.
• Compounded semaglutide and tirzepatide in standard clinical strengths, plus liraglutide, NAD+, and a full catalog of cGMP RUO research peptides.
• Third-party COAs on every product. Identity, purity, potency, sterility, and endotoxin testing from independent laboratories — not in-house testing.
• Cold chain overnight shipping Monday through Thursday. Orders placed by 5 PM ship next day.
• No portal fees. You pay for product. No subscription, no platform fee, no access charge.
• NPI-verified onboarding through the CMS registry. Most providers have portal access the same business day.
• Nationwide coverage. All 50 states.

Whether you work with MedClinic Partners or evaluate other options, here is what a compliant supply relationship looks like:

Independent third-party COAs. The certificate of analysis should come from an independent laboratory — not the compounding facility's own in-house testing. It should cover identity, purity, potency, sterility, and endotoxin. If a supplier cannot provide this documentation, that is a significant red flag.

Licensed facilities. Your 503A supplier should be licensed in your state. Your 503B supplier should be registered with the FDA. Verify both before placing an order.

Cold chain compliance. Compounded GLP-1 preparations require refrigerated shipping. Confirm that your supplier uses insulated packaging, temperature monitoring, and appropriate carrier protocols.

Transparent pricing. Understand what you are paying for. Some platforms charge portal fees, subscription fees, or access fees on top of product cost. Know the full cost structure before committing.

Supply chain documentation. If your practice is ever reviewed by a medical board, a payer, or an M&A buyer, your supply chain documentation will be scrutinized. Make sure your supplier can provide the documentation you need to demonstrate a defensible supply relationship.

The question is not just "where do I get compounded GLP-1s?" The question is "where do I get compounded GLP-1s from a supplier whose documentation standards, quality controls, and compliance infrastructure will hold up under scrutiny?"

That is the question MedClinic Partners was built to answer.

Get started at medclinicpartners.com/portal. NPI verification is automatic. Onboarding takes minutes. Your account representative will walk you through the product catalog, documentation standards, and supply arrangements.

Questions before applying? Email [email protected].